📋 Tender Overview
HC2 Holdings Inc. HC2 or the Company today announced that Glacial Rx an FDA-approved device developed by R2 Technologies was recently featured in RealSelf as one of the 2021 Launches Doctors are Buzzing About. R2 Technologies is an aesthetic medical device company dedicated to helping people experience amazing skin founded by HC2s portfolio company Pansend Life Sciences.The article From Groundbreaking Cellulite Treatments to New Injectables These Are the 2021 Launches Doctors Are Buzzing About stated that Glacial Rx is the first device to utilize unique cold-based technology to eliminate unwanted pigment.Dr. Arisa Ortiz MD FAAD Director of Laser and Cosmetic Dermatology at UC San Diego noted in the article the cool thing about this device is that you can titrate or adjust the settings to basically have no downtime and that because the temperature and exposure times are so precisely controlled there is much less risk of pigmentary changes compared to standard liquid nitrogen. RealSelf is a healthcare marketplace where consumers research aesthetic treatments and connect with physicians.Glacial Rx is expected to launch in 2021 and offers physicians an innovative method for treating aesthetic and medical skin conditions. The revolutionary system incorporates a first-of-its-kind dermal cooling technology as opposed to conventional heat-based laser treatments which can often cause inflammation and side effects. R2 seeks to capture a significant share of the 22 billion skin tone evening lightening and brightening products global market.